MYC and cancer: We investigated the differences in cancer hallmarks within the tumor TME between the two risk groups and found that the high-risk group was primarily enriched in pathways such as the G2M checkpoint, tumor proliferation signature, DNA replication, MYC targets, and cellular response to hypoxia (Supplementary Figure S6A).